granisetron IV
Selected indexed studies
- 2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies. (Headache, 2026) [PMID:41321235]
- Comparison of IV granisetron and IV palonosetron on hemodynamics and sensory and motor block after spinal anesthesia with hyperbaric bupivacaine in patients undergoing abdominal hysterectomy. (J Anaesthesiol Clin Pharmacol, 2019) [PMID:31303705]
- Pharmacodynamics of transdermal granisetron in women with nausea and vomiting of pregnancy. (Am J Obstet Gynecol, 2016) [PMID:26812081]
_Worker-drafted node — pending editorial review._
Connections
granisetron IV is a side effect of
Sources
- The efficacy and safety of metoclopramide in relieving acute migraine attacks compared with other anti-migraine drugs: a systematic review and network meta-analysis of randomized controlled trials. (2023) pubmed
- 2025 guideline update to acute treatment of migraine for adults in the emergency department: The American Headache Society evidence assessment of parenteral pharmacotherapies. (2026) pubmed
- IV Amisulpride (Barhemsys) for postoperative nausea and vomiting. (2020) pubmed
- Pharmacodynamics of transdermal granisetron in women with nausea and vomiting of pregnancy. (2016) pubmed
- Comparison of IV granisetron and IV palonosetron on hemodynamics and sensory and motor block after spinal anesthesia with hyperbaric bupivacaine in patients undergoing abdominal hysterectomy. (2019) pubmed
- Double-blind comparative trial of oral ondansetron versus oral granisetron versus IV ondansetron in the prevention of nausea and vomiting associated with highly emetogenic preparative regimens prior to stem cell transplantation. (2001) pubmed
- Effects of aprepitant on the pharmacokinetics of ondansetron and granisetron in healthy subjects. (2003) pubmed
- Prophylactic granisetron for post-spinal anesthesia shivering in cesarean section: A randomized controlled clinical study. (2019) pubmed
- Transdermal granisetron versus palonosetron for prevention of chemotherapy-induced nausea and vomiting following moderately emetogenic chemotherapy: a multicenter, randomized, open-label, cross-over, active-controlled, and phase IV study. (2016) pubmed
- Granisetron (IV) compared with ondansetron (IV plus oral) in the prevention of nausea and vomiting induced by moderately-emetogenic chemotherapy. A cross-over study. (1995) pubmed